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Abstract
Background: Thyroid dysfunction is associated with negative pregnancy outcomes.
There is a lack of reliable information on thyroid hormones in Iranian pregnant women,
especially in Yazd.
Objective: To determine the safe thyroid hormone levels in women of Yazd and also the
first trimester-specific reference ranges for serum thyroid-stimulating hormone (TSH),
thyroxine (T4), and triiodothyronine (T3).
Materials and Methods: In this cross-sectional study, the serum of 1,148 women in the
first trimester of pregnancy was analyzed. Thyroid function tests (TSH, T4, T3) were
measured through radioimmunoassay (RIA) [immunoradiometric (IRMA) for TSH]. The
study was conducted in Yazd, from September 2018 to November 2019. Reference
intervals were defined as the 5th, 50th, and 95th percentiles.
Results: The mean age of the participants was 28.78 (± 5.86 yr) (range: 15-45 yr). The
thyroid hormones reference intervals in the first trimester were TSH (0.2-3.8 mIU/l), T4
(7.45-12.75, 𝜇g/dl), and T3 (100-217 ng/dl).
Conclusion: The results of the present study determined a local thyroid function
measurement in the first trimester of pregnancy at a center of Yazd, Iran. This could
facilitate the decision-making of maternal TSH level during the first trimester of
pregnancy.
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1. Introduction
There is an association between thyroid
dysfunction in pregnancy, thyroid antibodies,
and negative pregnancy outcomes. Obvious
thyroid dysfunction is associated with numerous
complications and consequences during
pregnancy and postpartum (1). Maternal thyroid
hormones are critical in fetal development,
especially neural growth and development (1, 2).
However, there is insufficient evidence regarding
the association of subclinical thyroid disease
during pregnancy with the risk of gynecological
complications (3) and the preventive effects
of levothyroxine therapy (4, 5). Diagnosis of
subclinical hypothyroidism depends on the
trimester of pregnancy and the reference intervals
of thyroid tests and thyroid stimulating hormone
(TSH) tests (6).
Moreover, the reference intervals for thyroid
hormones depend on the ethnicity, iodine intake,
body size, and the method of assessment (6).
The National Academy of Clinical Biochemistry
(NACB) recommends that reference intervals for
TSH should be performed using samples of healthy
individuals excluding those with known goiter and
thyroid disease (7). Since there are no specific
TSH references recommendation for the three
trimesters of pregnancy for Yazd, Iran, the TSH
reference range is based on American Thyroid
Association (ATA) recommendations: 0.1-2.5 in the
first, 0.2-3 in the second, and 0.3-3 in the third
trimesters (8).
The World Health Organization recommends
that epidemiological criteria can be used to
evaluate the urinary iodine concentration (UIC)
based on nutrition in pregnant women (9). During
pregnancy, the median UICs between 150 µg/l
and 249 µg/l define a population which has
no iodine deficiency. Despite recent advances
in biochemical methods and the ability to better
understand the process of thyroid hormones in
pregnancy, there are no reliable reference ranges
in many countries, including some parts of Iran.
Moreover, the findings of previous studies are
inconsistent and cannot be generalized to our
community. The cause of variation include: urinary
iodine status, assay methods, and the inaccuracy
in selecting the reference population and sample
size.
The purpose of this study was the measurement
of maternal TSH levels in the first trimester of
pregnancy in Yazd, Iran.
2. Materials and Methods
2.1. Study design and participants
This is cross-sectional study included all
pregnant women who were referred to the
primary care clinics of Shahid Sadoughi University
of Medical Sciences in Yazd, Iran from September
2018 to November 2019.
There are 23 primary healthcare centers in Yazd
city and 12 primary care clinics that were visited by
pregnant women. For the purpose of this study, all
pregnant women in first trimester, from September
2018 to November 2019, were screened. The
information of 1,200 pregnant women in the first
trimester of pregnancy was gathered. However,
only 1,148 women who met the inclusion criteria
were included.
The inclusion criteria were: Yazd-native pregnant
women, in first trimester of pregnancy, age (15-45
yr). On the other hand, women with a history of
thyroid disease, goiter, twin or multiple recurrent
abortion, recurrent implantation failure, presence
or history of thyroid nodules (on examination), and
use of thyroid hormone replacement medication
were excluded. The gestational age for thyroid
hormone measurement (TSH, Thyroxine (T4), and
Triiodothyronine (T3)) was considered as 9-13 wk.
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They were screened by thyroid hormone tests
including TSH, T4, and T3.
All laboratory tests were done in the central
laboratory approved by the Yazd Shahid Sadoughi
University of Medical Sciences and Endocrinology
and Metabolism as a reference laboratory.
While the T4 and T3 were measured using
the radioimmunoassay (RIA) method, TSH was
measured by immunoradiometric (IRMA) for TSH
using commercial kits (Izotop, Budapest, Hungray)
and gamma counters (Wallac Wizard, Wallac Oy,
Turku, Finland). The urinary iodine levels in the
population of Yazd was measured in a pervious
study on students with acceptable urinary iodine
levels (18.82 ± 7.67 μg/dL). It can be concluded with
this study that Yazd region has sufficient iodine
intake (10).
2.2. Ethical considerations
The study proposal was presented to the Ethics
Committee of Shahid Sadoughi University of
Medical Sciences and approved by the Internal
Medicine Department. The Ethics Committee
approved the study (code: IR.SSU.REC.1396.131). In
addition, women were informed about the study
and each participant provided written consent
prior to the study.
2.3. Statistical analysis
Data were analysed using the Statistical
Package for the Social Sciences, version 18.0,
SPSS Inc., Chicago, Illinois, USA (SPSS). The
clinical and laboratory standards determined
the normal and reference values. Additionally,
Kolmogorov-Smirnov test was used to evaluate the
normal distribution of thyroid hormones.
The frequency was used to describe qualitative
variables and mean range, and standard deviation
for quantitative variables. Analysis of variance was
used to compare the mean thyroid hormones in
different months of pregnancy. The study sample
size was calculated according to the comparison
of two means formula, considering type-one error:
0.05 and power: 0.8.
3. Results
The mean age of the study population (1,148
pregnant women) was 28.78 ± 5.86 yr. After
applying the exclusion criteria, eligible pregnant
women were included in the study. After applying
the exclusion criteria, eligible pregnant women
were included in the study. As presented in Table I,
themean level of TSHwas 1.45±0.97mIU/l, T3was
133.14 ± 17.08 ng/dl, and T4 was 11.95 ± 8.28 µg/dl.
The first-trimester specific percentiles (5th, 50th,
and 95th) for TSH, T4, and T3, respectively, were
based on the data of this study (Table I). Reference
intervals in the first trimester were TSH (0.2-3.8
mIU/l), T4 (7.45-12.75, µg/dl), and T3 (100-217 ng/dl).
No correlation was found between TSH and T4 or
T3. Serum TSH had no significant correlation with
T4 and T3. No significant correlation was found
between the T4 and T3 in the first trimester (Figure
1A-1C).
Table I. The Mean, range of thyroid hormones, and gestation-specific percentile values for TSH, T4, and T3
Confidence interval Observed percentileTrimester Parameter* Bias* Std. error
Lower Upper 5th 50th 95th
TSH 1.45 ± 0.97 0.0004 ± 0.0002 0.1092 1.23 1.67 0.28 1.13 3.8
T4 11.95 ± 8.28 0.0088 ± 0.0095 1.20 10.01 14.56 7.45 10.5 12.87
T3 133.14 ± 17.08 0.16 ± 0.084 8.32 113.34 148.75 100 153.6 217
*Data presented as Mean ± SD, TSH: Thyroid-stimulating hormone, T4: Thyroxine, T3: Triiodothyronine
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Figure 1. Scatter plot of correlation between (A) TSH and T4; (B) TSH and T3; and (C) T4 and T3.
4. Discussion
Reference intervals in the first trimester were
TSH (0.2-3.8 mIU/l), T4 (7.45-12.75, 𝜇g/dl), and T3
(100-217 ng/dl). Thyroid disorders in pregnancy
are frequent and affect both the mother and
fetus’ health (11-13). There is a disagreement
about the normal range of TSH in pregnancy
and it is recommended that different populations
determine their reference ranges. ATA reference
range of TSH is 0.1-2.5 in the first trimester
of pregnancy (8). In this study, we reported
the first-trimester TSH, T3, and T4 levels in
pregnant women in Yazd. In Gorgan study,
with the similar methodology and different
laboratory methods (14), the mean of TSH was
1.31 mIU/L (range, 0.1-6.2). It was reported to
be 10% of the suppressive TSH population.
In this study, enzyme-linked immunosorbent
assay (ELISA), method was used to measure
the TSH. In the present study, the first trimester
of 5th and 95th percentiles TSH in this study
were 0.28 and 3.8, respectively, which is
similar to the TSH range of 0.2-3.9 reported
in the study of Mehran and colleague (15).
The present number is, however, higher than
in other studies except for a few studies in
India (16), United Arab Emirates (17), and China
(18) where 2.5th and 97.5th percentiles were
used and results for reference intervals with
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these laboratory kits are usually reported
lower.
Many factors are affected in reporting reference
ranges of thyroid hormones, such as maternal
iodine levels, laboratory techniques, ethnicity,
and methods of analysis. In our study, the TSH
levels over 4 mIU/L have been reported for a
limited number of individuals which may be due
to screening of women before pregnancy and
screening of hypothyroidism by endocrinologists in
Yazd city. Subsequently, higher TSH is diagnosed
earlier and many people are treated. In the present
study, the T4 range was 7.5-12.8 µg/dl and the
T3 range was 100-217 ng/dl in the 5th and 95th
percentiles. In the study of Mehran colleague
(15), the T4 range was reported as 7.5-12.8 µg/dl
and the T3 range as 100-217 ng/dl in the 5th
and 95th percentiles. Our results for T3 and T4
were inferior to that of Mehran L’s study, which
may be due to the differences in the laboratory
method. The laboratory method of our study was
RIA while in the study of Mehran and co-authors,
it was isotope dilution tandem mass spectrometry
(LC/MS/MS).
Furthermore, in the study of Kianpour and
colleague (19), the TSH, T3, and T4 were measured
by immunoassay and the mean levels of hormones
reported were 1.84 ± 1.32 mIU/L, 1.01 ± 0.15 ng/dl,
and 4.5 ± 0.64 pmol/L, respectively. Compared
to our results, the mean TSH was approximately
similar to that in the cited study. In the study
of Soldin and colleague (20), using the same
laboratory method like ours, the T3 and T4
ranges were reported as 92-218 ng/dl and 6.3-
14.6 µg/dl, respectively. The strength of our
study is the large number of cases that were
performed for the first time in Yazd province. The
limitations, on the other hand, were that the urinary
iodine was not measured in pregnant women
and the absence of data on anti-TPO thyroid
autoantibodies.
5. Conclusion
The reference range in our study is close to
the study of Mehran and colleague, which was
conducted in Tehran (District 3). However, the
ranges are higher than in European and American
countries. Given that the iodine levels in the urine
of pregnant women in Tehran are sufficient, this
rangemay also be appropriate for pregnant women
in Yazd.
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